Vitrafy Life Sciences Ltd (ASX:VFY – Get Free Report) insider John McBain purchased 28,255 shares of Vitrafy Life Sciences stock in a transaction dated Tuesday, March 18th. The shares were acquired at an average cost of A$1.36 ($0.86) per share, with a total value of A$38,426.80 ($24,167.80).
Vitrafy Life Sciences Stock Performance
Featured Stories
- Five stocks we like better than Vitrafy Life Sciences
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- What Makes a Stock a Good Dividend Stock?
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- How to Most Effectively Use the MarketBeat Earnings Screener
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Vitrafy Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrafy Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
